Dutta, Ritika
Vallurupalli, Mounica
McVeigh, Quinn
Huang, Franklin W. http://orcid.org/0000-0001-5447-0436
Rebbeck, Timothy R. http://orcid.org/0000-0002-4799-1900
Article History
Received: 31 August 2022
Accepted: 13 April 2023
First Online: 29 May 2023
Competing interests
: R.D. has received consulting fees from Acuta Capital Partners. Q.M. has received research funding from Bayer. A family member of T.R.R. is a consultant to AstraZeneca. All other authors declare no competing interests.